US9308281B2
(en)
|
2011-06-08 |
2016-04-12 |
Shire Human Genetic Therapies, Inc. |
MRNA therapy for Fabry disease
|
US11052159B2
(en)
|
2011-06-08 |
2021-07-06 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US9597413B2
(en)
|
2011-06-08 |
2017-03-21 |
Shire Human Genetic Therapies, Inc. |
Pulmonary delivery of mRNA
|
US11291734B2
(en)
|
2011-06-08 |
2022-04-05 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US11547764B2
(en)
|
2011-06-08 |
2023-01-10 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for MRNA delivery
|
US10888626B2
(en)
|
2011-06-08 |
2021-01-12 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US11338044B2
(en)
|
2011-06-08 |
2022-05-24 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US10350303B1
(en)
|
2011-06-08 |
2019-07-16 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US10413618B2
(en)
|
2011-06-08 |
2019-09-17 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US11254936B2
(en)
|
2012-06-08 |
2022-02-22 |
Translate Bio, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
US9181321B2
(en)
|
2013-03-14 |
2015-11-10 |
Shire Human Genetic Therapies, Inc. |
CFTR mRNA compositions and related methods and uses
|
US10420791B2
(en)
|
2013-03-14 |
2019-09-24 |
Translate Bio, Inc. |
CFTR MRNA compositions and related methods and uses
|
US10876104B2
(en)
|
2013-03-14 |
2020-12-29 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US10493031B2
(en)
|
2013-10-22 |
2019-12-03 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
US11377642B2
(en)
|
2013-10-22 |
2022-07-05 |
Translate Bio, Inc. |
mRNA therapy for phenylketonuria
|
US10208295B2
(en)
|
2013-10-22 |
2019-02-19 |
Translate Bio, Inc. |
MRNA therapy for phenylketonuria
|
US9522176B2
(en)
|
2013-10-22 |
2016-12-20 |
Shire Human Genetic Therapies, Inc. |
MRNA therapy for phenylketonuria
|
US10493166B2
(en)
|
2014-05-30 |
2019-12-03 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US10912844B2
(en)
|
2014-05-30 |
2021-02-09 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US10293057B2
(en)
|
2014-05-30 |
2019-05-21 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US10286083B2
(en)
|
2014-05-30 |
2019-05-14 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US10286082B2
(en)
|
2014-05-30 |
2019-05-14 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US11104652B2
(en)
|
2014-06-24 |
2021-08-31 |
Translate Bio, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
US11253605B2
(en)
|
2017-02-27 |
2022-02-22 |
Translate Bio, Inc. |
Codon-optimized CFTR MRNA
|
US12121592B2
(en)
|
2022-06-03 |
2024-10-22 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|